You are here
- Home
- Therapy Areas
- Oncology/Infection
A Phase I, Open-Label Study To Assess The Effect of ZD6474 (ZACTIMA) On Vascular Permeability In Patients with Advanced Colorectal Cancer and Liver Metastases.
- Disease
- solid tumour
- Drug Name
- Caprelsa
- Generic Name
- vandetanib
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- I
- Start Date
- Aug 15, 2006
- Study Name
- D4200C00050
- Study Id
- D4200C00050
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
